Liraglutide

For research use only.

Catalog No.S8256 Synonyms: Victoza, Liraglutida, Liraglutidum, NN2211, NN-2211

3 publications

Liraglutide Chemical Structure

Molecular Weight(MW): 3751.25

Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.

Size Price Stock Quantity  
USD 197 In stock
USD 697 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective Glucagon Receptor Inhibitors

Biological Activity

Description Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist.
Targets
GLP-1 receptor [1]
()
In vitro

Liraglutide attenuates induction of plasminogen activator inhibitor type-1 (PAI-1) and vascular adhesion molecule (VAM) expression in human vascular endothelial cells (hVECs) in vitro and may afford protection against endothelial cell dysfunction (ECD), an early abnormality in diabetic vascular disease. In vitro studies demonstrates GLP-1R-dependent liraglutide-mediated inhibition of stimulated PAI-1 and VAM expression[3].

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HepG2 NXzxTW11WHKxbHnm[ZJifGmxbjDhd5NigQ>? MWmwMEAyNCBzMDygNVAxNCCjbnSgNVAxOCCwbX;sM2w> NUeyXZlrPDhiaB?= MVLJR|UxhjFyMDDuUS=> NWHtOHNnOzFyOEGxNFg>
MiaPaca-2 M130WmNmdGxidnnhZoltcXS7IHHzd4F6 NEDrOXoxNCBzMDygNVAxNCBzMECwJI5O Ml3qOFghcA>? MYTUbIUhcW6qaXLpeI9zgSCnZn\lZ5R{KG:wIHPlcIwhfmmjYnnsbZR6KGGwZDDj[YxtKG63bXLldkB4\XKnIIP0ZZRqe3SrY3HscJkhe2mpbnnmbYNidnRib37sfUBifCC2aHWgZ49v[2WwdILheIlwdiCxZjCxMFAxOCCwbX;sM2wh\m:{IHzpdoFodHW2aXTl NXTvTXhxOjl6OUe5PVg>
H9c2 M2fES2Z2dmO2aX;uJIF{e2G7 NEmxe5AyODEkgL;uUS=> NI\IWnYyKGh? MoDVUIlz[WeudYTp[IUhemW4ZYLz[YQhfGinIHTve45z\We3bHH0bY9vKG:oIGPJVnQyKGmwZIXj[YQh[nliVF7GMe6yKGGwZDDofZBwgGmj MWOyPVU4OTd|Nh?=
MC3T3-E1 Mkj0RZBweHSxc3nzJIF{e2G7 NXixV3hpOCxiMUCsJFExOCxib4KgNVAxOCCwTR?= MmO5OFghcA>? NHzzUWptcXKjZ3z1eIll\SC|dYDwdoV{e2WmIITo[UBieG:ydH;zbZMhd2ZiTVOzWFMuTTFiY3XscJM> Ml\SNlk1PjNyNke=
MCF-7 M2H2NHBzd2yrZnXyZZRqd25iYYPzZZk> MYmxNEwhOTByLDCxMFAxOCCjbnSgNVAtODByIH7N M12zVlQ5KGh? NFG0b2ZNcXKjZ3z1eIll\SCrbnjpZol1eyC2aHWgdJJwdGmoZYLheIlwdiCjbnSgdJJwdW:2ZYOgZZBweHSxc3nzJIlvKHSqZTDNR2YuPyCkcnXhd5Qh[2GwY3XyJINmdGxibHnu[S=> MnzTNlk{QTN2NUm=
SH-SY5Y MYPGeY5kfGmxbjDhd5NigQ>? NGTGeoMyODEkgJnuUS=> MYixOkBp M3;jWWxqemGpbIX0bYRmKHKnc3;seoV{KFWSUjDpckB1cGVibnX1do9jdGG|dH;tZUBUUC2VWUXZJINmdGxibHnu[U4> MnezNlkyPzB2NUK=

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-ERK / p-JNK / p-p38 / p-AKT / IκB-α ; 

PubMed: 24217090     


Panel C shows the liraglutide-induced signaling cascade activation. Results for phospho-ERK, phospho-JNK, phospho-p38, and phospho-Akt were determined using specific phospho-antibodies. Results with IκB-α were determined using a specific IκB-α antibody. The results were determined at the indicated times with liraglutide and after a 15 min incubation with PDGF-BB.

24217090
In vivo In vivo studies of vascular reactivity and immunohistochemical analysis are performed in the ApoE-/- mouse model. They demonstrate significant improvement in endothelial function in liraglutide treated mice, a GLP-1R dependent effect. Liraglutide treatment also increases endothelial nitric oxide synthase (eNOS) and reduces intercellular adhesion molecule-1 (ICAM-1) expression in aortic endothelium, an effect again dependent on the GLP-1R[3]. Liraglutide reduces hyperglycemia in T2D mouse models by increasing pancreatic b cell mass through enhanced proliferation[2].

Protocol

Cell Research:

[3]

- Collapse
  • Cell lines: human umbilical vein endothelial cell line C11-STH20
  • Concentrations: 100 nM
  • Incubation Time: 16 h
  • Method:

    C11-STH cells are cultured to confluence at 37°C in gelatin-coated Nunclon cell culture dishes in Media-199 supplemented with penicillin/streptomycin, 20% FCS, 20 µg/ml endothelial cell growth factor and 20 µg/ml heparin. C11-STH cells are incubated under serum free conditions with liraglutide (100 nM) or the GLP-1 receptor antagonist exendin (9-39) (100 nM) alone or with 10 ng/ml TNFα for 16 h alone or in combination with liraglutide and/or exendin (9-39). ELISA assays for VCAM-1 and ICAM-1 are performed using conditioned medium from C11-STH cells to determine protein expression levels.


    (Only for Reference)
Animal Research:

[2]

- Collapse
  • Animal Models: Athymic nude mice
  • Dosages: 300 μg/kg/day
  • Administration: s.c.
    (Only for Reference)

Solubility (25°C)

In vitro Water 100 mg/mL (26.65 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 3751.25
Formula

C172H265N43O51

CAS No. 204656-20-2
Storage powder
in solvent
Synonyms Victoza, Liraglutida, Liraglutidum, NN2211, NN-2211

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation (Different batches have different solubility ratios, please contact Selleck to provide you with the correct ratio)
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04057261 Not yet recruiting Drug: Liraglutide Pen Injector [Victoza]|Drug: Placebo Type 2 Diabetes|Cardiovascular Diseases RWTH Aachen University|Novo Nordisk A/S November 2020 Phase 3
NCT04373967 Not yet recruiting Drug: Victoza®.|Drug: Metformin Hydrochloride|Drug: TQZ2451 Type 2 Diabetes Chia Tai Tianqing Pharmaceutical Group Co. Ltd. May 1 2020 Phase 3
NCT04008290 Not yet recruiting Drug: 0.6 mg Liraglutide|Drug: Placebo Obesity Universitaire Ziekenhuizen Leuven April 1 2020 Phase 4
NCT03888157 Active not recruiting Drug: Liraglutide Diabetes Mellitus Type 2 Novo Nordisk A/S March 10 2019 --

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    I want to know whether S8256 Liraglutide is free base or salt form?

  • Answer:

    Our S8256 Liraglutide is a TFA salt.

Tags: buy Liraglutide | Liraglutide supplier | purchase Liraglutide | Liraglutide cost | Liraglutide manufacturer | order Liraglutide | Liraglutide distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID